Displaying drugs 626 - 650 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Dequalinium | 456.6654 C30H40N4 |  | A quaternary ammonium cation antimicrobial agent used to treat common infections of the mouth and throat, as well as vaginal candidiasis. | Anti-Infective Agents, Local / Quinoline Derivatives |
| Delavirdine | 456.561 C22H28N6O3S |  | A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection. | Non-Nucleoside Reverse Transcriptase Inhibitors |
| Flavin mononucleotide | 456.3438 C17H21N4O9P |  | A form of vitamin B2 used to restore riboflavin in anemia, migraine, alcoholism, and hyperhomocysteinemia. | Ribonucleotides / Vitamin B Complex |
| Clevidipine | 456.316 C21H23Cl2NO6 |  | A dihydropyridine L-type calcium channel blocker used to lower blood pressure when oral antihypertensive therapy is not feasible or not desirable. | Dihydropyridine Derivatives |
| Zinc gluconate | 455.67 C12H22O14Zn |  | An ingredient found in a variety of supplements and vitamins. | Zinc Compounds |
| Lacidipine | 455.551 C26H33NO6 |  | A lipophilic dihydropyridine calcium channel blocker with a slow onset of action used to treat hypertension. | Dihydropyridine Derivatives |
| Cefotaxime | 455.465 C16H17N5O7S2 |  | A third generation cephalosporin used to treat susceptible Gram negative and Gram positive bacterial infections. | Agents that reduce seizure threshold |
| Halcinonide | 454.96 C24H32ClFO5 |  | A corticosteroid used for the management and symptomatic relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. | Corticosteroids, Very Potent (Group IV) |
| Sitaxentan | 454.905 C18H15ClN2O6S2 |  | Investigated for use/treatment in pulmonary hypertension, connective tissue diseases, hypertension, and congestive heart failure. | Antihypertensives for Pulmonary Arterial Hypertension |
| Tivozanib | 454.863 C22H19ClN4O5 |  | A kinase inhibitor to treat adult patients with renal cell carcinoma (RCC) who have failed prior systemic therapies or experienced relapsed disease. | Protein Kinase Inhibitors / Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| Verapamil | 454.6016 C27H38N2O4 |  | A non-dihydropyridine calcium channel blocker used in the treatment of angina, arrhythmia, and hypertension. | ACE Inhibitors and Calcium Channel Blockers / Phenylalkylamine Derivatives |
| Cefazolin | 454.507 C14H14N8O4S3 |  | A broad-spectrum cephalosporin antibiotic mainly used for the treatment of skin bacterial infections and other moderate to severe bacterial infections in the lung, bone, joint, stomach, blood, heart valve, and urinary tract. | Anti-Bacterial Agents / Cephalosporins / First-Generation Cephalosporins |
| Ribostamycin | 454.4727 C17H34N4O10 |  | A broad spectrum aminoglycoside antibiotic on the list of WHO critical antimicrobials for human medicine. | Anti-Bacterial Agents |
| Methotrexate | 454.4393 C20H22N8O5 |  | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. | Folic Acid Analogues |
| Flucloxacillin | 453.872 C19H17ClFN3O5S |  | A narrow spectrum penicillin antibiotic that exerts specific activity against Gram positive organisms in skin and soft tissue infections, except those caused by methicillin resistant staphylococcus aureus (MRSA). | Beta-Lactamase Resistant Penicillins |
| Copper gluconate | 453.841 C12H22CuO14 |  | An ingredient found in a variety of supplements and vitamins. | Sugar Acids |
| Netarsudil | 453.542 C28H27N3O3 |  | A rho kinase inhibitor used to reduce intraocular pressure in patients with open angle glaucoma or ocular hypertension. | Prostaglandins, Synthetic |
| Cefixime | 453.45 C16H15N5O7S2 |  | A third generation cephalosporin used to treat susceptible Gram-negative and Gram-positive bacterial infections. | beta Lactam Antibiotics |
| Diphenoxylate | 452.5873 C30H32N2O2 |  | An antidiarrheal medication used with atropine to manage diarrhea. | Antipropulsives / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Repaglinide | 452.5857 C27H36N2O4 |  | A antihyperglycemic used to improve glycemic control in diabetes. | Glinide / Stereoisomerism |
| Tafluprost | 452.5313 C25H34F2O5 |  | An ophthalmic prostaglandin analog used to lower intraocular pressure in patients with ocular hypertension or open-angle glaucoma. | Prostaglandins, Synthetic |
| Belumosudil | 452.518 C26H24N6O2 |  | An oral inhibitor of rho-associated coiled-coil-containing protein kinases (ROCK) used in the treatment of chronic graft-versus-host disease (GVHD). | Selective Immunosuppressants |
| Fluocinolone acetonide | 452.4882 C24H30F2O6 |  | A corticosteroid used to treat skin conditions, eczematous otitis externa, diabetic macular edema, and non-infectious uveitis of the posterior segment of the eye. | Corticosteroids / Pregnadienes / Steroids, Fluorinated |
| Lumacaftor | 452.414 C24H18F2N2O5 |  | A protein chaperone used in combination with ivacaftor for the treatment of cystic fibrosis in patients who are homozygous for the F508del mutation in the CFTR gene. | Amines / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Inducers / Cytochrome P-450 CYP2C19 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Inhibitors / Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inducers (strong) / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strong) / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Dioxoles / Heterocyclic Compounds, Fused-Ring / P-glycoprotein inducers / P-glycoprotein inhibitors / Pyridines |
| Betrixaban | 451.91 C23H22ClN5O3 |  | A Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients. | Direct factor Xa inhibitors |
Displaying drugs 626 - 650 of 2785 in total